DIATOMIC Launches its Final Call to Distribute up to €200K Equity-Free Funding

In its second and final open call for application experiments, DIATOMIC is offering a total of €1.610.000 equity-free funding plus acceleration services to the best startups/ SMEs and Competence Centers across the European microelectronics industry.

DIATOMIC, an exclusive network of Digital Innovation Hubs - set under the EC's Smart Anything Everywhere Initiative, aims to accelerate solutions that apply electronic components, sensors, smart objects and systems across health, agrifood and manufacturing sectors. With this in mind, DIATOMIC offers a 9 - 15 months acceleration programme, and will distribute up to €1.610.000 equity-free funding, with selected consortia receiving up to €200,000 per application experiment.

Eligibility

  • We are only looking for small consortia of a maximum of 3 partners from the EU and H2020 associated countries;
  • Your consortium must include technology providers in the areas of advanced microelectronics & smart systems integration (i.e. Centers of Competence), as well as tech adopters/ users, namely: startups/ SMEs active in health, agrifood, manufacturing;
  • The consortia is to be led by industrial partners - SMEs & midcaps. DIATOMIC also provides assistance in partner search/ matchmaking;
  • Your solution needs to demonstrate clear value to the European economy and society. The minimum TRL required at time of proposal submission should be at the level 3, aiming towards the digitization of products/processes.

The Offer

Top consortiaselected after the closing date on 31stJanuary, 2019, will take part in an intensive, milestone-driven acceleration programme, designed around 3-stages, each of which is a step closer to market entry: 'Design', 'Develop', 'Market'.

Some high-level benefits include:

  • up to €200K equity-free funding per application experiment;
  • personalized technical and business development support;
  • novel testbed and experimentation facilities;
  • awareness-raising, matchmaking, networking activities;
  • access to investment opportunities;

How to Apply?

The deadline for applications - to be submitted at f6s.com/diatomic-opencall2 - is 31 January 2019. For tips and resources on the application process, check out diatomic.eu. For questions, or to request partner search/ matchmaking support, get in touch: f6s.com/diatomic.

About DIATOMIC

DIATOMIC is a network of Digital Innovation Hubs funded under the European Smart Anything Everywhere Initiative. Eight consortia have already been selected for funding and acceleration in the first DIATOMIC Open Call. Each of the top consortia is expected to create significant value resulting from new microelectronics-enabled products, processes, and business models. The second (and final)call for application experimentscloses on 31stJanuary 2019.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 761809.

Most Popular Now

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Abbott to Launch the NeuroSphere™ myPath…

Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...